Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

A decision point between transdifferentiation and programmed cell death priming controls

ABSTRACT: A decision point between transdifferentiation and programmed cell death priming controls

PROVIDER: PRJNA1190954 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

A decision-point between programmed cell death and transdifferentiation in pancreatic cancer

Project description:Transdifferentiation and changes of cellular identity are hallmarks of malignant transformation1-3. As such, the process of acinar-to-ductal metaplasia (ADM) represents a fundamental step in pancreatic ductal adenocarcinoma (PDAC) development, but regulatory pathways controlling ADM are not fully understood4,5. Here, we show that murine pancreatic acinar cells upregulate expression of CASPASE3, CASPASE8, RIPK3 and MLKL - key molecules driving both apoptosis and necroptosis6,7 - during transdifferentiation towards a duct-like phenotype. Spontaneous activation of these respective programmed cell death (PCD) pathways during KRAS-driven transdifferentiation is counterbalanced by transforming growth factor (TGF)-β-activated kinase 1 (TAK1), a kinase transmitting inhibitory phosphorylation signals towards the apoptosis- and necroptosis activator RIPK18. Genetic deletion or pharmacological inhibition of TAK1 simultaneously triggered apoptosis and necroptosis and thereby prevented KRAS-driven ADM in vitro as well as KRAS-driven PDAC in vivo. In line, TAK1 expression is upregulated in human PDAC cells, and pharmacological inhibition of TAK1 triggered PCD in organoid and spheroid cells derived from PDAC patients. Collectively, these findings suggest that TAK1 defines a decision point between ADM and PCD in pancreas cells and represents a promising pharmacological target for the prevention and treatment of PDAC patients.

2024-11-29 | GSE223135 | GEO

A decision-point between programmed cell death and transdifferentiation in pancreatic cancer

Project description:A decision-point between programmed cell death and transdifferentiation in pancreatic cancer

| PRJNA1151076 | ENA

A decision-point between programmed cell death and transdifferentiation in pancreatic cancer

Project description:A decision-point between programmed cell death and transdifferentiation in pancreatic cancer

| PRJNA925118 | ENA

A decision point between transdifferentiation and programmed cell death priming controls

Project description:The involvement of cell death pathways in the early stage of pancreatic ductal adenocarcinoma (PDAC) development, especially KRAS-dependent acinar-to-ductal metaplasia (ADM), remains to be investigated. Here, we show that TAK1 mediates cell survival during ADM transdifferentiation through suppression of Caspase-8/3-dependent apoptosis and RIPK3-MLKL-dependent necroptosis, which could be targeted for prevention and treatment of PDAC. Given that mutations are a driving force of PDAC development and TAK1 might modulate chromosomal stability and the mutational spectrum of PDAC via NF-κB, we performed an array comparative genomic hybridization (aCGH) analysis on pancreatic tissue of five KRASG12D TAK1/CASP8ΔAc RIPK3-/- mice and five KRASG12D mice. Interestingly, both genotypes showed distinct chromosomal abnormalities with gain or loss of genetic regions. Further analysis of these chromosomal regions showed they contained genes known to be involved in the pathogenesis of human PDAC, such as Trp53, Cdkn2a, Smad4, Rnf43 and Arid1a. However, we did not observe a consistent pattern of chromosomal/gene alterations in the majority of samples/tumors between KRASG12D single transgenic mice and KRASG12D TAK1/CASP8ΔAc RIPK3-/- mice, arguing against the hypothesis that TAK1 deficiency mediated late stages of tumor promotion through changes in chromosomal stability.

2024-11-26 | GSE282891 | GEO

A decision-point between programmed cell death and transdifferentiation in pancreatic cancer

Project description:Mecanism of action of TAK inhibitor on immune cells and cancer cells extracted from pancreatic tumor (PDAC)

2024-11-28 | GSE275488 | GEO

Interleukin-27 priming of T cells controls Interleukin-17-production in trans via induction of Programmed cell death ligand 1

Project description:Interleukin (IL)-27 is a key immunosuppressive cytokine that counters T helper 17 (Th17) cell-mediated pathology. To identify mechanisms by which IL-27 might exert its immunosuppressive effect, we analyzed genes in T cells rapidly induced by IL-27. We found that IL-27 priming of naïve T cells upregulated expression of programmed death ligand 1 (PD-L1) in a signal transducer and activator of transcription (STAT)1-dependent manner. When co-cultured with naïve CD4+ T cells, IL-27-primed T cells inhibited the differentiation of Th17 cells in trans through a PD-1-PD-L1 interaction. In vivo, co-administration of naïve TCR transgenic T cells (2D2 T cells) with IL-27-primed T cells expressing PD-L1 inhibited the development of Th17 cells and protected from severe autoimmune encephalomyelitis. Thus, these data identify a suppressive activity of IL-27, by which CD4+ T cells can restrict differentiation of Th17 cells in trans. The roles of IL-6 and IL-27 in naïve CD4+ T cells was investigated by comparing global gene expression by Affymetrix Mouse Genome 430 2.0 Arrays. The functional outcome of STAT proteins was further evaluated by profiling gene expression changes between WT and STAT-deficient T cells in naïve CD4+ T cells with specific stimulation. All condition were done in biological triplicate.

2012-06-30 | E-GEOD-38375 | biostudies-arrayexpress

Programmed genomic instability regulates neural transdifferentiation of human brain microvascular pericytes [ATAC-Seq]

Project description:Programmed genomic instability regulates neural transdifferentiation of human brain microvascular pericytes [ATAC-Seq]

| PRJNA777273 | ENA

Programmed genomic instability regulates neural transdifferentiation of human brain microvascular pericytes [DRIP-Seq]

Project description:Programmed genomic instability regulates neural transdifferentiation of human brain microvascular pericytes [DRIP-Seq]

| PRJNA777271 | ENA

Programmed genomic instability regulates neural transdifferentiation of human brain microvascular pericytes [ChIP-Seq]

Project description:Programmed genomic instability regulates neural transdifferentiation of human brain microvascular pericytes [ChIP-Seq]

| PRJNA777272 | ENA

Programmed genomic instability regulates neural transdifferentiation of human brain microvascular pericytes [RNA-Seq]

Project description:Programmed genomic instability regulates neural transdifferentiation of human brain microvascular pericytes [RNA-Seq]